Gilgamesh Pharmaceuticals, a Clinical stage biotechnology companyβ¦
Company is active
Event Year: 2020
Company is active
Event Year: 2020
Gilgamesh Pharmaceuticals is an innovative clinical-stage biotechnology company dedicated to advancing mental health science. The company maintains a focused approach on the development of novel chemical entities (NCEs). This is achieved through the strategic integration of medicinal chemistry, a robust intellectual property strategy, deep understanding of neuroscience and neurobiology, and extensive drug development expertise. The Gilgamesh team possesses considerable experience and a track record of success in biotech exits and groundbreaking inventions, positioning them as leaders in the field.
Gilgamesh Pharmaceuticals is an innovative clinical-stage biotechnology company dedicated to advancing mental health science. The company maintains a focused approach on the development of novel chemical entities (NCEs). This is achieved through the strategic integration of medicinal chemistry, a robust intellectual property strategy, deep understanding of neuroscience and neurobiology, and extensive drug development expertise. The Gilgamesh team possesses considerable experience and a track record of success in biotech exits and groundbreaking inventions, positioning them as leaders in the field.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2020
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2020
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 15
Hiring: No
Team size: 15
Hiring: No